Hangzhou Adcoris Biopharmacy Co., Ltd
Hangzhou Adcoris Biopharmacy Co., Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2025-11-24 | NCT06238401 | |
| Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors | HER2-positive Advanced Solid Tumor | Enrolling by invitation | Phase 1 | 2025-09-30 | NCT05423977 |